Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: Multicenter randomized trial

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 2020-2026

  Takada, Tadahiro ^a   Nimura, Yuji ^b   Katoh, Hiroyuki ^c   Nagakawa, Takakazu ^d   Nakayama, Toshimichi ^e   Matsushiro, Takashi ^f   Amano, Hodaka ^a   Wada, Keita ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^e KURUME UNIVERSITY   (Japan)

^f Japan Labour Health and Welfare Organization   (Japan)

Author keywords

Bile duct carcinoma; Chemotherapy; FAM chemotherapy; Gallbladder carcinoma; Pancreatic carcinoma

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; GALLBLADDER CARCINOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PALLIATIVE THERAPY; PANCREAS CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032415443     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Takada T, Kato H, Matsushiro T, et al: Comparison of 5-Fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic biliary carcinomas. Oncology 1994; 51:396-400.
2. Smith FP, Hoth DF, Levin B, et al: 5-Fluorouracil, adriamycin, and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 1980; 46:2014-2018.
3. Koyama Y, Saito T: Chemotherapy efficacy evaluation criteria for solid cancer of the Japanese Cancer Therapy Society. J Can Ther 1986; 21:931-942.
4. Cullinan SA, Moertel CG, Fleming TR, et al: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. JAMA 1985; 253:2061-2067.
5. WHO Handbook for Reporting Results of Cancer Treatment (1979). WHO, Geneva.
6. Koyama Y, Saito T: Evaluation criteria for enhanced chemotherapeutic effects in solid cancer of the Japanese Cancer Therapy Society. J Can Ther 1986; 21:943-953.
7. Zimmerman SE, Smith FP, Schein PS: Chemotherapy for pancreatic carcinoma. Cancer 1981; 47:1724-1728.
8. Bukowski RM, Schacter LP, Groppe CW, et al: Phase trial of 5-fluorouracil, adriamycin, mitomycin C and streptozotocin (FAM-S) in pancreatic carcinoma. Cancer 1982; 50:197-200.
9. The Gastrointestinal Tumor Study Group: Phase studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. J Clin Oncol 1986; 4:1794-1798.
10. Oster MW, Gray R, Panasci L, et al: Chemotherapy for advanced pancreatic cancer. Cancer 1986; 57:29-33.
11. Mallinson CN, Rake MO, Cocking JB, et al: Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomized, multicentre trial. Br Med J 1980; 281:1589-1591
12. Cullinan SA, Moertel CG, Wieand HS, et al: A phase trial on the therapy of advanced pancreatic carcinoma. Cancer 1990; 65:2207-2212.
13. Harvey JH, Smith FP, Schein PS: 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 1984; 2:1245-1248.
14. Hall SW, Benjamin RS, Murphy WK, et al: Adriamycin, BCNU, Futorafur chemotherapy of pancreatic and biliary tract cancer. Cancer 1979; 44:2008-2013.
15. Falkson G, MacIntyre JM, Moertel CG: Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984; 54:965-969.
16. Wagener DJ, van Hoesel QGCM, Yap SH, et al: Phase trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer. Cancer Chemotherapy Pharmacology 1989; 25:131-134.